Immunologic Effects of Emdogain in Humans: One-Year Results

International Journal of Periodontics and Restorative Dentistry

Volumn 22, Issue 3, 2002, Pages 269-277

  Nikolopoulos, Symeon ^a   Peteinaki, Efthymia ^c   Castanas, Elias ^b  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ENAMEL MATRIX PROTEINS; ENAMEL PROTEIN;

ANALYSIS OF VARIANCE; ANIMAL; ANTIBODY PRODUCTION; ARTICLE; BONE REGENERATION; CELLULAR IMMUNITY; DRUG EFFECT; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE; OSTEOLYSIS; SWINE;

ALVEOLAR BONE LOSS; ANALYSIS OF VARIANCE; ANIMALS; ANTIBODY FORMATION; BONE REGENERATION; DENTAL ENAMEL PROTEINS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; LYMPHOCYTES; SWINE;

EID: 0036615565     PISSN: 01987569     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Janeway CAJ, Travers P. T-cell immunity. In: Immunobiology. The Immune System in Health and Disease. London: Current Biology, 1996:7.1-7.41.
2. Janeway CAJ, Travers P. The host's response to infections. In: Immunobiology. The Immune System in Health and Disease. London: Current Biology, 1996:9.1-9.46.
3. Chen E, Piddington R, Decker S, et al. Regulation of amelogenic gene expression during tooth development. Dev Dyn 1994;189-198.
4. Deutsch D, Catalano-Sherman J, Dafni L, David S, Palmon A. Enamel matrix proteins and ameloblast biology. Connect Tissue Res 1995;32:97-107.
5. Fong CD, Slaby I, Hammarström L. Amelin: An enamel-related protein, transcribed in the cells of epithelial root sheath. J Bone Miner Res 1996;11: 892-898.
6. Gestrelius S, Andersson C, Lidström D, Hammarström L, Somerman M. In vitro studies on periodontal ligament cells and enamel matrix derivative. J Clin Periodontol 1997;24:685-692.
7. Gestrelius S, Andersson C, Johansson A-C, et al. Formulation of enamel matrix derivative for surface coating. Kinetics and cell colonization. J Clin Periodontol 1997;24:678-684.
8. Hamamoto Y, Nakajima T, Ozawa H, Uchida T. Production of amelogenin by enamel epithelium of Hertwig's root sheath. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;81:703-709.
9. Hammarström L. Enamel matrix, cementum development and regeneration. J Clin Periodontol 1997;24:658-668.
10. Sasaki S, Shimokawa H. The amelogenin gene. Int J Dev Biol 1995;39:127-133.
11. Sculean A, Donos N, Windisch P, et al. Healing of human intrabony defects following treatment with enamel matrix proteins or guided tissue regeneration. J Periodontal Res 1999;34:310-322.
12. Heden G, Wennström J, Lindhe J. Periodontal tissue alterations following Emdogain treatment of periodontal sites with angular bone defects. A series of case reports. J Clin Periodontol 1999;26: 855-860.
13. Heijl L, Heden G, Svardström G, Östgren A. Enamel matrix derivative (Emdogain) in the treatment of intrabony periodontal defects. J Clin Periodontol 1997;24: 705-714.
14. Pontoriero R, Wennström J, Lindhe J. The use of barrier membranes and enamel matrix proteins in the treatment of angular bone defects. A prospective controlled clinical study. J Clin Periodontol 1999;26: 833-840.
15. Sculean A, Reich E, Chiantella GC, Brecx M. Treatment of intrabony periodontal defects with an enamel matrix protein derivative (Emdogain): A report of 32 cases. Int J Periodontics Restorative Dent 1999;19:157-163.
16. Peteinaki E, Nikolopoulos S, Castanas E. Low stimulation of peripheral lymphocytes following in vitro application of Emdogain. J Clin Periodontol 1998;25: 715-720.
17. Zetterström O, Andersson C, Eriksson L, et al. Clinical safety of enamel matrix derivative (Emdogain) in the treatment of periodontal defects. J Clin Periodontol 1997;24:697-704.
18. Brookes SJ, Robinson C, Kirkham J, Bonass WA. Biochemistry and molecular biology of amelogenin proteins of developing dental enamel. Arch Oral Biol 1995;40:1-14.
19. Kampa M, Loukas S, Hatzoglou A, Martin P, Martin P-M, Castanas E. Identification of a novel opioid peptide derived from alpha-S1 human casein (alpha-S1 casomorphin, and alpha-S1 casomorphinamide). Biochem J 1996;319:903-908.
20. Meisel H, Frister H, Schlimme E. Biologically active peptides in milk proteins. Z Emahrungswiss 1989;28:267-278.
21. Schlimme E, Meisel H. Bioactive peptides derived from milk proteins. Structural, physiological, and analytical aspects. Nahrung 1995;39:1-20.
22. Goodman NJ. The immune response. In: Stiles DP, Terr AJ (eds). Basic and Clinical Immunology, ed 7. New York: Prentice-Hall, 1991:34-44.
23. Weiss A. T-lymphocyte activation. In: Paul WE (ed). Fundamental Immunology, ed 3. New York: Raven, 1993:467-507.
24. Feldmann N, Dower S, Brennan FM. The role of cytokines in normal and pathological situations. In: Cytokines in Autoimmunity. Austin, Tex: RG Landes, 1996:1-9.
25. Kaplan D. Autocrine secretion and the physiological concentration of cytokines. Immunol Today 1996;17:174-176.
26. McLennan ICM, Lui Y-J, Johnson GD. Maturation and dispersal of B-cell clones during t cell-dependent antibody responses. Immunol Rev 1992;126: 143-161.